Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the New York Stock Exchange. The company will be offering 20.0 million Class A stocks on the big board under the symbol “BLND”.

The offering price is expected to be between US$16.00 to US$18.00 per share for potential total aggregate proceeds of up to US$360.0 million. The financial software company also gave the underwriters a 30-day option to purchase an additional 3,000,000 common shares.

In the prospectus filed, the San Francisco-based fintech company recorded US$31.9 million in revenue and a US$27.1 million net loss for Q1 2021. The company also raised US$300.0 million in its last round of funding in January 2021, putting the company’s valuation at US$3.3 billion. The proposed public offering seeks to bring this up to US$3.95 billion.

Goldman Sachs & Co., Allen & Company, and Wells Fargo Securities are all managing the offering as lead underwriters. 


Information for this briefing was found via Blend. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Eldorado Gold: The $3.8 Billion Foran Mining Acquisition

Silver Tiger’s $2.35B Silver Blueprint: Two Mines, One Perfect Metals Market

Gold Is At Records. Barrick Mining Is Printing Cash. The Stock Still Fell. | Q4 Earnings

Recommended

Canadian Copper Plans 2,500 Metre Drill Program For 2026

Mercado Receives Permits For Planned 3,000 Metre Drill Program At Copalito

Related News

Cannabis-Focused Finance Company Altmore Capital Files For Nasdaq IPO

Specialty finance company Altmore BDC, Inc., also known as Altmore Capital, is looking to go...

Wednesday, February 9, 2022, 02:27:00 PM

Green Energy SPAC ClimateRock Prices US$75 Million IPO

Special purpose acquisition company ClimateRock (Nasdaq: CLRCU) started trading publicly on the Nasdaq Global Market...

Friday, April 29, 2022, 02:22:00 PM

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the...

Tuesday, July 27, 2021, 10:47:00 AM

Financial SPAC FG Acquisition Announces US$100 Million TSX IPO

Blank check firm FG Acquisition is looking to go public on the Toronto Stock Exchange....

Tuesday, March 22, 2022, 02:18:00 PM

ISP Starry Debuts On NYSE Via US$176 Million SPAC Deal

Wireless technology developer and internet service provider Starry, Inc, (NYSE: STRY) made its debut on...

Wednesday, March 30, 2022, 02:26:00 PM